VERIFY RESI-TEST SWAB Protein Detection Indicator
STERIS · Decision date Oct 28, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-28 for K260822, the VERIFY RESI-TEST SWAB Protein Detection Indicator, submitted by Steris of Mentor, Ohio. The device falls under the classification name Qualitative Cleaning Process Protein Indicator, product code SDC, with a regulation medical specialty and review panel of General Hospital. The application was received 03/13/2026 as a Traditional 510(k); the record shows it was not reviewed by a third party, not a combination product, and had no authorized predetermined change control plan.
SESE denotes 510(k) clearance rather than PMA approval, and the record does not establish the predicate device, the specific comparison basis, or any performance data supporting the determination. The public page also does not describe the swab's components, intended cleaning-process use, or labeling claims. Those details, along with any clinical or legal interpretation of the clearance's scope, remain outside the available source and should be confirmed against the full FDA decision documents.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General Hospital
- Decision date
- Oct 28, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260822
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- STERIS
- Product code
- SDC
- Decision code
- SESE
- Decision date
- Oct 28, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Qualitative Cleaning Process Protein Indicator.
FDA decision timeline
K260822 received
Application receipt date recorded by FDA.
K260822 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Steris
- Headquarters
- Not reported
- Brand website
- steris.com
- FDA applicant address
- Mentor, OH
Sources and methodology
- Original FDA record: K260822
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records